By DrBicuspid Staff

March 27, 2018 -- GlaxoSmithKline (GSK) has acquired Novartis' minority stake in the companies' consumer healthcare joint venture for $13 billion. The buyout means GSK has full control over the Sensodyne toothpaste brand and other consumer products.

The joint venture between the companies was approved in 2014 with Novartis holding a 36.5% stake. The buyout is expected to close during the summer of 2018, according to GSK.

GSK Consumer Healthcare's portfolio includes products such as Parodontax, Poligrip, and Theraflu.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking